Approved

• The Indian Sports Ministry has officially approved a 492-member contingent to compete in the upcoming Asian Games held in Aichi-Nagoya, Japan. • The delegation consists of 265 male and 227 female athletes, with athletics serving as the largest sporting group with 73 participants. • High-profile stars, including Neeraj Chopra and Jyothi Yarraji, are among the selected athletes representing the nation.

• The FDA has approved Pasatru™ (garetosmab-grts) as the first and only treatment to reduce new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with Fibrodysplasia Ossificans Progressiva (FOP). • The approval follows the OPTIMA Phase 3 clinical trial, a multinational study designed to evaluate the drug's efficacy, safety, tolerability, and pharmacokinetics in patients with active FOP. • This development is significant as it provides a targeted therapeutic option for a rare disease, supported by previous Fast Track and Orphan Drug designations from the FDA, EMA, and Japan's Ministry of Health.

Greens say analysis shows government failure to take bold climate action could lead to big gains for party at electionUK politics live – latest updatesLabour could lose dozens of seats to the Green party if the government allows new drilling in the North Sea, according to internal research shared with the Guardian.Green party analysis suggests up to 50 Labour MPs – including key Andy Burnham ally Louise Haigh – could lose their seats at the next election if the government fails to make urgent climate action a priority or allows new drilling for oil and gas in the North Sea. Continue reading...

• The U.S. Food and Drug Administration (FDA) has officially approved a new mRNA-based vaccine designed to combat influenza. • Despite this milestone, experts caution that the approval does not necessarily signal a broad government embrace of mRNA technology for all vaccines. • This development is significant as it expands the application of mRNA platforms beyond COVID-19, potentially streamlining the response to seasonal flu mutations.

• An FDA advisory panel narrowly voted to recommend allowing compounding pharmacies to produce BPC-157 and KPV, two popular but unproven peptides. • The decision follows advocacy from Robert F. Kennedy Jr., who pushed for increased access to these substances despite their lack of formal FDA approval. • This move is significant as it challenges standard regulatory hurdles for unapproved drugs, potentially expanding patient access to experimental treatments.

• In August 2025, US scientists conducted the first federally approved ocean alkalinity enhancement experiment by releasing 16,500 gallons of sodium hydroxide (lye) into the Gulf of Maine. • The operation utilized a bright pink dye to track the spread of the lye plume across the water's surface. • This initiative aims to reverse rising ocean acidity and increase the ocean's capacity to absorb CO2 from the atmosphere to combat climate change.

• The FCC has approved a test demonstration for Reflect Orbital, a company developing satellites designed to reflect sunlight to Earth after sunset. • The project aims to reduce reliance on fossil fuels during peak electricity demand spikes that typically occur around sundown. • While only one satellite is currently cleared, Reflect Orbital intends to eventually deploy a constellation of 50,000 satellites into orbit.

Exclusive: Most of the island’s corals are likely to be species that have not been formally described by science, researcher saysGet our breaking news email, free app or daily news podcastScientists fear unique corals that fringe Australia’s remote Norfolk Island could disappear because of a triple threat of disease, El Niño and a federal government plan to dredge a neighbouring shipping channel.A failure to manage sediment and pollution washing into bays from cattle farming, cleared land along with wastewater has been blamed for widespread disease and outbreaks of algae over the corals. Continue reading...

New study on fluazinam’s neurotoxicity comes up with different findings from earlier report based on manufacturer’s dataResearchers who re-ran a crucial fungicide study on neurotoxicity have come up with significantly different findings, and campaigners argue that the substance should now be withdrawn from the market.In 2005, a study conducted by Huntingdon Life Sciences on behalf of ISK, the manufacturer of fluazinam, on the development of neurotoxicity of fluazinam in pregnant rats concluded there were no statistically significant effects in relation to brain development in the rats’ offspring. Continue reading...

• The FDA approved the updated COVID-19 vaccine strain in May, but official guidance on who should receive it remains unavailable. • A critical lack of a quorum since March has stalled the committee responsible for determining eligibility and insurance coverage for the fall rollout. • This administrative gap creates uncertainty for healthcare providers and patients regarding the timing and necessity of booster shots.